Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viswanath Devanarayan

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Bioanalysis|January 15, 2015
Recommendations for adaptation and validation of commercial kits for biomarker quantification in drug developmentMasood U Khan, Ronald R Bowsher, Mark Cameron, et al.
The AAPS Journal|July 13, 2022
Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry ConsortiumMarta Starcevic Manning, Mohamed Hassanein, Michael A Partridge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 28, 2024
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's diseaseViswanath Devanarayan, Thomas Doherty, Arnaud Charil, et al.
International Journal of Cancer|January 5, 2002
A very early induction of major vault protein accompanied by increased drug resistance in U-937 cellsYi Hu, Andrew G Stephen, Jin Cao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2025
Multimodal prognostic modeling of individual cognitive trajectories to enhance trial efficiency in preclinical Alzheimer's diseaseViswanath Devanarayan, Michael C Donohue, Reisa A Sperling, et al.
Journal of Immunological Methods|July 15, 2004
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology productsAnthony R Mire-Sluis, Yu Chen Barrett, Viswanath Devanarayan, et al.
The AAPS Journal|December 4, 2019
Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar ProgramsFrancesca Civoli, Aparna Kasinath, Xiao-Yan Cai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2024
Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's diseaseViswanath Devanarayan, Arnaud Charil, Kanta Horie, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 11, 2008
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsGopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.
Bioanalysis|January 19, 2018
Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdlesJoanne Goodman, Simon Cowen, Viswanath Devanarayan, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Bioanalysis|January 15, 2015
Recommendations for adaptation and validation of commercial kits for biomarker quantification in drug developmentMasood U Khan, Ronald R Bowsher, Mark Cameron, et al.
The AAPS Journal|July 13, 2022
Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry ConsortiumMarta Starcevic Manning, Mohamed Hassanein, Michael A Partridge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 28, 2024
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's diseaseViswanath Devanarayan, Thomas Doherty, Arnaud Charil, et al.
International Journal of Cancer|January 5, 2002
A very early induction of major vault protein accompanied by increased drug resistance in U-937 cellsYi Hu, Andrew G Stephen, Jin Cao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2025
Multimodal prognostic modeling of individual cognitive trajectories to enhance trial efficiency in preclinical Alzheimer's diseaseViswanath Devanarayan, Michael C Donohue, Reisa A Sperling, et al.
Journal of Immunological Methods|July 15, 2004
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology productsAnthony R Mire-Sluis, Yu Chen Barrett, Viswanath Devanarayan, et al.
The AAPS Journal|December 4, 2019
Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar ProgramsFrancesca Civoli, Aparna Kasinath, Xiao-Yan Cai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2024
Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's diseaseViswanath Devanarayan, Arnaud Charil, Kanta Horie, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 11, 2008
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsGopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.
Bioanalysis|January 19, 2018
Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdlesJoanne Goodman, Simon Cowen, Viswanath Devanarayan, et al.
Pageof 7